Skip to main content
Premium Trial:

Request an Annual Quote

Can Take Part

The European Commission has scuttled plans to prevent the UK from participating in certain space and supercomputing projects, the Guardian reports.

It adds that Thierry Breton, the EU internal market commissioner, had identified the UK's involvement in the projects as a potential security risk, arguing that the EU had to keep control of its intellectual property. But the move to prevent the UK from participating in the projects led to a backlash from research institutions and member nations. According to the Guardian, diplomats raised concerns the UK was being treated as if it posed as much of a threat to security as China. Following negotiations, the EU determined the exclusion of the UK from certain projects would have to be run past member states, it adds.

"It is still possible for UK entities to be excluded from certain calls, but only based on objective criteria that have been drafted in collaboration with member states," a diplomat tells the Guardian.

As part of its trade deal with the Europe Union, the UK can take part in the Horizon Europe program, so long as it pays into it.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.